{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T23:49:26Z","timestamp":1782258566964,"version":"3.54.5"},"reference-count":35,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:00:00Z","timestamp":1739491200000},"content-version":"vor","delay-in-days":655,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jvsvenous.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Vascular Surgery: Venous and Lymphatic Disorders"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.jvsv.2022.11.004","type":"journal-article","created":{"date-parts":[[2022,12,24]],"date-time":"2022-12-24T22:01:17Z","timestamp":1671919277000},"page":"543-552","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Incidence of venous thromboembolism in patients with sickle cell disease undergoing noncardiovascular surgery"],"prefix":"10.1016","volume":"11","author":[{"given":"Samuel K.","family":"Osei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham W.","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aryana","family":"Sharrak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nardin","family":"Derias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"Rocelious","family":"Goodson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rose E.","family":"Callahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane M.","family":"Studzinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O. William","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvsv.2022.11.004_bib1","doi-asserted-by":"crossref","first-page":"18808","DOI":"10.1073\/pnas.1104964108","article-title":"Forced TR2\/TR4 expression in sickle cell disease mice confers enhanced fetal hemoglobin synthesis and alleviated disease phenotypes","volume":"108","author":"Campbell","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jvsv.2022.11.004_bib3","doi-asserted-by":"crossref","first-page":"454","DOI":"10.3389\/fimmu.2020.00454","article-title":"The red blood cell-inflammation vicious circle in sickle cell disease","volume":"11","author":"Nader","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jvsv.2022.11.004_bib4","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/180326a0","article-title":"Gene mutations in human haemoglobin: the chemical difference between normal and sickle cell haemoglobin","volume":"180","author":"Ingram","year":"1957","journal-title":"Nature"},{"key":"10.1016\/j.jvsv.2022.11.004_bib5","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.cca.2019.02.026","article-title":"Sickle cell disease: hemostatic and inflammatory changes, and their interrelation","volume":"493","author":"Toledo","year":"2019","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jvsv.2022.11.004_bib6","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ejim.2005.02.010","article-title":"Should the sickle cell trait be reclassified as a disease state?","volume":"16","author":"Ajayi","year":"2005","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.jvsv.2022.11.004_bib7","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ajme.2011.10.007","article-title":"Plasma levels of soluble endothelial protein C-receptor in patients with \u03b2-thalassemia","volume":"48","author":"Elgammal","year":"2012","journal-title":"Alexandria J Med"},{"key":"10.1016\/j.jvsv.2022.11.004_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1053\/ejvs.2002.1778","article-title":"Incidence of diagnosed deep vein thrombosis in the general population: systematic review","volume":"25","author":"Fowkes","year":"2003","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.jvsv.2022.11.004_bib9","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/bjh.14655","article-title":"Increased incidence of VTE in sickle cell disease patients: risk factors, recurrence and impact on mortality","volume":"178","author":"Brunson","year":"2017","journal-title":"Br J Haematol"},{"issue":"Suppl","key":"10.1016\/j.jvsv.2022.11.004_bib10","doi-asserted-by":"crossref","first-page":"132S","DOI":"10.1378\/chest.119.1_suppl.132S","article-title":"Prevention of venous thromboembolism","volume":"119","author":"Geerts","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.jvsv.2022.11.004_bib11","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1001\/jama.2010.378","article-title":"Acute care utilization and re-hospitalizations for sickle cell disease","volume":"303","author":"Brousseau","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.jvsv.2022.11.004_bib12","doi-asserted-by":"crossref","first-page":"897.e7","DOI":"10.1016\/j.amjmed.2006.08.015","article-title":"Deep venous thrombosis and pulmonary embolism in hospitalized patients with sickle cell disease","volume":"119","author":"Stein","year":"2006","journal-title":"Am J Med"},{"issue":"Suppl 1","key":"10.1016\/j.jvsv.2022.11.004_bib13","first-page":"IV4","article-title":"Prevention of venous thromboembolism in surgical patients","volume":"110","author":"Agnelli","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jvsv.2022.11.004_bib14","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.2106\/00004623-199808000-00010","article-title":"Ultrasound surveillance for asymptomatic deep venous thrombosis after total joint replacement","volume":"80","author":"Ciccione","year":"1998","journal-title":"J\u00a0Bone Joint Surg Am"},{"key":"10.1016\/j.jvsv.2022.11.004_bib15","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.injury.2018.05.018","article-title":"Perioperative incidence and locations of deep vein thrombosis following specific isolated lower extremity fractures","volume":"49","author":"Wang","year":"2018","journal-title":"Injury"},{"key":"10.1016\/j.jvsv.2022.11.004_bib16","doi-asserted-by":"crossref","first-page":"S187","DOI":"10.1016\/j.jcot.2018.10.007","article-title":"Thrombosis rates using aspirin and a compression device as multimodal prophylaxis for lower limb arthroplasty in a screened population","volume":"11","author":"An","year":"2020","journal-title":"J\u00a0Clin Orthop Trauma"},{"key":"10.1016\/j.jvsv.2022.11.004_bib17","first-page":"129","article-title":"Thromboprophylaxis in surgical patients","volume":"46","author":"O\u2019Donnell","year":"2003","journal-title":"Can J Surg"},{"key":"10.1016\/j.jvsv.2022.11.004_bib18","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/S0741-5214(97)70088-0","article-title":"Screening for asymptomatic deep vein thrombosis in surgical intensive care patients","volume":"26","author":"Harris","year":"1997","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvsv.2022.11.004_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta9490","article-title":"Toward evidence-based guidelines of the prevention of venous thromboembolism: systematic reviews of mechanical methods, oral anticoagulation, dextran and regional anaesthesia as thromboprophylaxis","volume":"9","author":"Roderick","year":"2005","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.jvsv.2022.11.004_bib20","doi-asserted-by":"crossref","first-page":"e278S","DOI":"10.1378\/chest.11-2404","article-title":"Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"141","author":"Falck-Ytter","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.jvsv.2022.11.004_bib21","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1200\/JCO.19.01461","article-title":"Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO clinical practice guideline update","volume":"38","author":"Key","year":"2020","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jvsv.2022.11.004_bib22","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.soard.2010.02.046","article-title":"Extended thromboprophylaxis reduces incidence of postoperative venous thromboembolism in laparoscopic bariatric surgery","volume":"6","author":"Magee","year":"2010","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/j.jvsv.2022.11.004_bib23","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00277-015-2531-8","article-title":"Venous thromboembolism in adults with sickle cell disease: experience of a single centre in the UK","volume":"95","author":"van Hamel Parsons","year":"2016","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jvsv.2022.11.004_bib24","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.chest.2015.11.026","article-title":"Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report","volume":"149","author":"Kearon","year":"2016","journal-title":"Chest"},{"key":"10.1016\/j.jvsv.2022.11.004_bib25","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1080\/17474086.2019.1583554","article-title":"Overcoming challenges of venous thromboembolism in sickle cell disease treatment","volume":"12","author":"Ogunsile","year":"2019","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.jvsv.2022.11.004_bib26","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/s11239-018-1637-y","article-title":"Effectiveness and safety of oral anticoagulants in patients with sickle cell disease and venous thromboembolism: a retrospective cohort study","volume":"45","author":"Roberts","year":"2018","journal-title":"J\u00a0Thromb Thrombolysis"},{"key":"10.1016\/j.jvsv.2022.11.004_bib27","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1177\/1060028016681129","article-title":"Outcomes of rivaroxaban use in patients with sickle cell disease","volume":"51","author":"Bhat","year":"2017","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jvsv.2022.11.004_bib28","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1161\/CIRCULATIONAHA.116.024507","article-title":"Association of traditional cardiovascular risk factors with venous thromboembolism: an individual participant data meta-analysis of prospective studies","volume":"135","author":"Mahmoodi","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jvsv.2022.11.004_bib29","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5152\/TJAR.2019.08683","article-title":"Influence of tobacco smoking on perioperative risk of venous thromboembolism","volume":"48","author":"Al-Nasser","year":"2020","journal-title":"Turk J Anaesthesiol Reanim"},{"key":"10.1016\/j.jvsv.2022.11.004_bib30","first-page":"848","article-title":"Prospective evaluation of patients hospitalized with venous thromboembolism: comparison between cancer and non-cancer patients","volume":"8","author":"Kolomansky","year":"2006","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.jvsv.2022.11.004_bib31","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1200\/JCO.2003.05.165","article-title":"Markers of coagulation and angiogenesis in cancer-associated venous thromboembolism","volume":"21","author":"Goldenberg","year":"2003","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jvsv.2022.11.004_bib32","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1046\/j.1537-2995.1994.34694295059.x","article-title":"Epidemiology of blood transfusion","volume":"34","author":"Vamvakas","year":"1994","journal-title":"Transfusion"},{"key":"10.1016\/j.jvsv.2022.11.004_bib33","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1111\/trf.13676","article-title":"Trends in United States blood collection and transfusion: results from the 2013 AABB blood collection, utilization, and patient blood management survey","volume":"56","author":"Whitaker","year":"2016","journal-title":"Transfusion"},{"key":"10.1016\/j.jvsv.2022.11.004_bib34","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1055\/s-0039-1697664","article-title":"Blood transfusion and risk of venous thromboembolism: a population-based cohort study","volume":"120","author":"Lin","year":"2020","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jvsv.2022.11.004_bib35","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1001\/jamasurg.2018.1565","article-title":"Association of perioperative red blood cell transfusions with venous thromboembolism in a North American registry","volume":"153","author":"Goel","year":"2018","journal-title":"JAMA Surg"},{"key":"10.1016\/j.jvsv.2022.11.004_bib36","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.amjmed.2012.12.016","article-title":"Venous thromboembolism in adults with sickle cell disease: a serious and under-recognized complication","volume":"126","author":"Naik","year":"2013","journal-title":"Am J Med"}],"container-title":["Journal of Vascular Surgery: Venous and Lymphatic Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213333X2200498X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213333X2200498X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T07:03:07Z","timestamp":1761980587000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213333X2200498X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S2213333X2200498X"],"URL":"https:\/\/doi.org\/10.1016\/j.jvsv.2022.11.004","relation":{},"ISSN":["2213-333X"],"issn-type":[{"value":"2213-333X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence of venous thromboembolism in patients with sickle cell disease undergoing noncardiovascular surgery","name":"articletitle","label":"Article Title"},{"value":"Journal of Vascular Surgery: Venous and Lymphatic Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvsv.2022.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 by the Society for Vascular Surgery. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}